VIM and Löfgren’s syndrome: A pronounced response of T-cells of the bronchoalveolar fluid to vimentin and citrullinated vimentin was also demonstrated in patients with the HLA genotype DR-B1*0301 and acute forms of the disease, which was confirmed in patients with Löfgren’s syndrome in our study [9].